Gülsah Kolak Gözükücük
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Gülsah Kolak Gözükücük has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Kübra Cullu
Department of Thoracic Surgery, Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Istanbul, Türkiye
1 shared publication - Muhammet Kertmen
Thoracic Surgery Department, Basaksehir Çam ve Sakura City Hospital, 34480 Istanbul, Turkey
1 shared publication - Nur Büyükpınarbaşılı
Department of Pathology, Başakşehir Çam ve Sakura City Hospital, İstanbul, Türkiye
1 shared publication - Turkan Dubus
Department of Thoracic Surgery, Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Istanbul, Turkey
1 shared publication
Latest Publications
- Open Access
- 30 December 2025
- Published by University of Rzeszow in European Journal of Clinical and Experimental Medicine
- Vol. 23 (4) , 1088-1092
Postoperative diagnosis of pulmonary actinomycosis in a patient with bronchiectasis ‒ a rare case
Introduction and aim. Pulmonary actinomycosis is a rare chronic infection caused by Actinomyces species, often mimicking tuberculosis, malignancy, or other chronic lung diseases both clinically and radiologically. These similarities frequently lead to diagnostic delays. We present a rare case of pulmonary actinomycosis in a patient with long-standing bronchiectasis who developed acute hemoptysis during anticoagulant therapy. Description of the case. A 59-year-old woman with a ten-year history of bronchiectasis and recent mechanical aortic valve replacement presented with persistent hemoptysis while on warfarin. Thoracic computed tomography revealed bronchiectatic changes and opacities in the right middle lobe. Bronchoscopy showed bloody, encrusted material, but no definitive diagnosis was made. Due to ongoing symptoms and radiological suspicion of malignancy, an urgent right middle lobectomy was performed. Histopathological analysis confirmed pulmonary actinomycosis, revealing filamentous organisms via PAS, Gram, and Grocott’s staining. Conclusion. This case highlights the importance of considering pulmonary actinomycosis in patients with bronchiectasis and unexplained hemoptysis, particularly when standard treatment fails. Surgical resection may be essential for both diagnosis and treatment. The case underscores how structural lung disease and anticoagulant use can reveal rare infections otherwise masked by chronic symptoms.
- 30 December 2025
- Published by University of Rzeszow in European Journal of Clinical and Experimental Medicine
- Vol. 23 (4) , 1088-1092
Open AccessPostoperative diagnosis of pulmonary actinomycosis in a patient with bronchiectasis ‒ a rare case
Introduction and aim. Pulmonary actinomycosis is a rare chronic infection caused by Actinomyces species, often mimicking tuberculosis, malignancy, or other chronic lung diseases both clinically and radiologically. These similarities frequently lead to diagnostic delays. We present a rare case of pulmonary actinomycosis in a patient with long-standing bronchiectasis who developed acute hemoptysis during anticoagulant therapy. Description of the case. A 59-year-old woman with a ten-year history of bronchiectasis and recent mechanical aortic valve replacement presented with persistent hemoptysis while on warfarin. Thoracic computed tomography revealed bronchiectatic changes and opacities in the right middle lobe. Bronchoscopy showed bloody, encrusted material, but no definitive diagnosis was made. Due to ongoing symptoms and radiological suspicion of malignancy, an urgent right middle lobectomy was performed. Histopathological analysis confirmed pulmonary actinomycosis, revealing filamentous organisms via PAS, Gram, and Grocott’s staining. Conclusion. This case highlights the importance of considering pulmonary actinomycosis in patients with bronchiectasis and unexplained hemoptysis, particularly when standard treatment fails. Surgical resection may be essential for both diagnosis and treatment. The case underscores how structural lung disease and anticoagulant use can reveal rare infections otherwise masked by chronic symptoms.